EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis
27 August 2021
ESC Premium Access
Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.